Reports

Sale

Cardiac Mapping Systems Market

Global Cardiac Mapping Systems Market Share, Size, Forecast: By Type: Contact Cardiac Mapping Systems, Electroanatomical Mapping Systems, Basket Catheter Mapping Systems, Others; By Indication; By End-User; Regional Analysis; Current Scenario Evaluation; Challenges & Unmet Needs; Supplier Landscape; 2024-2032

Global Cardiac Mapping Systems Market

The global cardiac mapping systems market was estimated to be worth USD 1.84 billion in 2023. By 2032, the market value is anticipated to be worth USD 3.84 billion, rising at a CAGR of 8.50% in the forecast period of 2024-2032.

 

cardiac mapping systems market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Company News

  • In April 2023, Royal Philips launched a novel cardiac mapping system, KODEX-EPD, for enhanced imaging techniques. This will assist the physicians in getting precise information before the ablation procedures.
  • In January 2023, FDA approved Abbott’s new cardiac mapping system, the Ensite X electrophysiology system. This system will help detect and manage cardiac arrhythmias by producing a detailed three-dimensional image of the heart.
  • In January 2023, Medtronic, one of the leading key players, announced its acquisition with Affera, a Boston-based MedTech company, to expand its cardiac mapping systems product portfolio.

 

Introduction

Cardiac mapping systems are the mapping devices used to measure the heart’s electrical impulses and create an extensive three-dimensional image of the heart’s anatomy. These systems map the different cardiac arrhythmias, including tachycardia, bradycardia, and premature ventricular contractions.

 

Cardiac mapping systems are non-invasive and need to be placed on the chest. Cardiac mapping helps detect the spatial and temporal areas during a specific heart rhythm. The healthcare technician can perform cardiac mapping on the required area of interest for a particular heart rhythm.

 

A cardiac mapping system generally consists of several equipments like amplifiers, recorders, and analysing systems or analysers. Cardiac mapping is performed with the help of catheters. These catheters are inserted into the heart chambers to record the electrocardiograms, which can be visualised on screen.

 

The cardiac data analysis on the screen is being done to study the heart's anatomy. These catheters can be localised or positioned using the fluoroscopy technique.

 

According to the cardiac mapping systems market research report, the market can be categorised into the following segments:

 

cardiac mapping systems market by segments

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Breakup by Type

  • Contact Cardiac Mapping Systems
  • Electroanatomical Mapping Systems
  • Traditional Endocardial Catheter Mapping Systems
  • Basket Catheter Mapping Systems
  • Non-Contact Cardiac Mapping Systems

 

Market Breakup by Indication Type

  • Atrial Flutter
  • Atrioventricular Nodal Reentry Tachycardia (AVNRT)
  • Atrial Fibrillation
  • Other Arrhythmias

 

Market Breakup by End-User

  • Hospitals
  • Testing Laboratories
  • Research Laboratories
  • Individual

 

Market Breakup by Region

  • North America
  • United States of America
  • Canada
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

 

cardiac mapping systems market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increased Prevalence of Cardiovascular Diseases and Rise in Product Launches are Aiding the Market Growth

Rising Prevalence of Cardiovascular Disorders

The increasing prevalence of cardiovascular disorders drives the cardiac mapping systems market growth. According to the European Health Network, around 19 million people suffer from cardiovascular diseases every year. With the growing population, there is an increase in the incidence of cardiac disorders. This is further propelling the market growth.

 

Product Launches and Approvals

Due to the extensive research by clinical scientists, novel products are being discovered. The launch of these products will help in the expansion of the cardiac mapping systems market. For example, in 2020, a leading company, BioSense Webster, launched a new cardiac mapping system that is more efficient than conventional cardiac mapping systems.

 

Another key factor boosting the growth of this market is product approvals. The regulatory bodies of different countries have become more cooperative and approved more products, thus increasing the cardiac mapping systems market size.

 

For example, Abbott got approval for its cardiac mapping system, Ensite X, in Australia and Europe, providing significant impetus to the market growth.

 

Therapeutic Landscape

Cardiac mapping is a broad term covering several types of mapping. The different modes of cardiac mapping are epicardial, endocardial, and body surface mapping.

 

Modes of Cardiac Mapping Systems

There are different modes in cardiac mapping systems. Some of the major modes in cardiac mapping systems include activation mapping, entrainment mapping, and pace mapping.

 

Activation mapping works on the principle of electrocardiogram tracings to detect the direction and type of impulse propagation. Entrainment mapping is used to visualise the location of the circuit, which can be helpful while performing ablation. Pace mapping is another mode in which the tachycardia sources are plotted by pacing at several endocardial sites.

 

The cardiac mapping systems help visualise and analyse the heart’s electrical activity. This data is used to diagnose and manage cardiovascular disorders at the early stages or at the onset of that disease.

 

These devices also help map the heart’s anatomy before and after the ablation process. This mapping is done to ensure whether the surgery is effective or not.

 

Treatment Of Cardiac Arrhythmias

The cardiac mapping systems market is majorly driven by its use in treating cardiac arrhythmias. The different arrhythmias managed by these systems include ventricular tachycardia, atrial fibrillation, ventricular bradycardia, and untimely ventricular contractions.

 

With the high treatment potential, the cardiac mapping systems market possesses an excellent opportunity for healthcare industries and pharmaceutical companies in extensive therapeutic and diagnostic methods.

 

Latest Industry Trends Include the Rapid Technological Advancements, Incorporation of 3-D Technology and Hybrid Systems

Rising Technological Advancements

Increasing technological advancements have paved the way for multiple approaches to cardiac mapping systems. These novel technologies provide more specific and sensitive data. The technological advancements have resulted in the production of magnetic-based mapping systems and impedance-based mapping systems., which have further aided the market growth.

 

Incorporation Of Three-Dimensional technology

The 3-D technology is used to create highly detailed images of the heart’s anatomy, which helps cardiologists detect abnormal heart rhythm regions. Such technology is likely to provide an impetus to the market growth in the coming years as well.

 

The Invention of Hybrid Systems

The emergence of hybrid magnetic and impedance-based systems has provided novel prospects in the cardiac mapping systems market. This incorporated system is being used to create the heart’s anatomical map. In this system, a magnetic system is used to get the accurate image, while impedance systems help provide users with flexibility for using any catheter.

 

With the advancements in electrophysiology, novel and more effective technologies have been invented. These technologies are under clinical trials and, once approved, are anticipated to drive the growth of the market during the forecast period.

 

Competitive Landscape

The report gives an in-depth analysis of the key players involved in the cardiac mapping systems market, sponsors manufacturing the therapies, and putting them through trials to get FDA approvals. The companies included in the market are as follows:

 

  • Biosense Webster
  • Abbott Laboratories
  • Medtronics PLC
  • Boston Scientific Corporation
  • Acutus Medical
  • Microport Scientific Corporation
  • CoreMap Inc.
  • APN Health LLC
  • BioSig Technologies Inc.
  • Biotronik SE and Co KG
  • Koninklijke Philips NV
  • Angiodynamics

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Demand by Indication
  • End-User
  • Region
Breakup by Type
  • Contact Cardiac Mapping Systems
  • Electroanatomical Mapping Systems
  • Basket Catheter Mapping Systems
  • Traditional Endocardial Catheter Mapping Systems
  • Non-Contact Cardiac Mapping Systems
Breakup Demand by Indication
  • Atrial Fibrillation
  • Atrial Flutter
  • Atrioventricular Nodal Reentry Tachycardia (Avnrt)
  • Other Arrhythmias
Breakup by End-User
  • Hospitals
  • Testing Laboratories
  • Research Laboratories
  • Individual
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Trade Data Analysis
  • Major Exporting Countries
    • By Value
    • By Volume
  • Major Importing Countries
    • By Value
    • By Volume
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Biosense Webster
  • Abbott Laboratories
  • Medtronics PLC
  • Boston Scientific Corporation
  • Acutus Medical
  • Microport Scientific Corporation
  • CoreMap Inc.
  • APN Health LLC
  • BioSig Technologies Inc.
  • Biotronik SE and Co KG
  • Koninklijke Philips NV
  • Angiodynamics

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
    1.1    Objectives of the Study
        1.1.1     Research Objectives
        1.1.2     Key Findings of the Report
    1.2    Limitations of the Study and Scope for Future Research
2    Research Methodology
3    Executive Summary
4    Global Cardiac Mapping System Market 

    4.1    Global Cardiac Mapping System Market Overview
        4.1.1    Global Cardiac Mapping System Market Analysis 
            4.1.1.1     Market Overview
                4.1.1.1.1    Global Cardiac Mapping System Historical Market Value (2017-2023) 
                4.1.1.1.2    Global Cardiac Mapping System Forecast Market Value (2024-2032)
        4.1.2    Global Cardiac Mapping System Market by Type
            4.1.2.1    Market Overview
                4.1.2.1.1    Contact Cardiac Mapping Systems
                4.1.2.1.2    Electroanatomical Mapping Systems
                4.1.2.1.3    Basket Catheter Mapping Systems
                4.1.2.1.4    Traditional Endocardial Catheter Mapping Systems
                4.1.2.1.5    Non-Contact Cardiac Mapping Systems
        4.1.3    Global Cardiac Mapping System Market demand by Indication
            4.1.3.1     Market Overview 
                4.1.3.1.1    Atrial Fibrillation
                4.1.3.1.2    Atrial Flutter
                4.1.3.1.3    Atrioventricular Nodal Reentry Tachycardia (Avnrt)
                4.1.3.1.4    Other Arrhythmias
        4.1.4    Global Cardiac Mapping System Market by End-User 
            4.1.4.1    Market Overview
                4.1.4.1.1    Hospitals
                4.1.4.1.2    Testing Laboratories
                4.1.4.1.3    Research Laboratories 
                4.1.4.1.4    Individual
        4.1.5    Global Cardiac Mapping System by Region
            4.1.5.1    Market Overview
                4.1.5.1.1    North America
                4.1.5.1.2    Europe 
                4.1.5.1.3    Asia Pacific
                4.1.5.1.4    Latin America
                4.1.5.1.5    Middle East & Africa
        4.1.6    North America
            4.1.6.1    Historical Trend (2017-2023)
            4.1.6.2    Forecast Trend (2024-2032)
            4.1.6.3    Break Up by Country
                4.1.6.3.1    United States of America
                4.1.6.3.2    Canada
        4.1.7    Europe
            4.1.7.1    Historical Trend (2017-2023)
            4.1.7.2    Forecast Trend (2024-2032)
            4.1.7.3    Break Up by Country
                4.1.7.3.1    United Kingdom
                4.1.7.3.2    Germany
                4.1.7.3.3    France
                4.1.7.3.4    Italy
                4.1.7.3.5    Others
        4.1.8    Asia Pacific
            4.1.8.1    Historical Trend (2017-2023)
            4.1.8.2    Forecast Trend (2024-2032)
            4.1.8.3    Break Up by Country
                4.1.8.3.1    China
                4.1.8.3.2    Japan
                4.1.8.3.3    India
                4.1.8.3.4    ASEAN
                4.1.8.3.5    Australia
                4.1.8.3.6    Others
        4.1.9    Latin America
            4.1.9.1    Historical Trend (2017-2023)
            4.1.9.2    Forecast Trend (2024-2032)
            4.1.9.3    Break Up by Country
                4.1.9.3.1    Brazil
                4.1.9.3.2    Argentina
                4.1.9.3.3    Mexico
                4.1.9.3.4    Others
        4.1.10    Middle East and Africa
            4.1.10.1    Historical Trend (2017-2023)
            4.1.10.2    Forecast Trend (2024-2032)
            4.1.10.3    Break Up by Country
                4.1.10.3.1    Saudi Arabia
                4.1.10.3.2    United Arab Emirates
                4.1.10.3.3    Nigeria
                4.1.10.3.4    South Africa
                4.1.10.3.5    Others
5    Trade Data Analysis by HS Code 
6    Regulations and Current Scenario Evaluation 

    6.1    Regulatory Framework
    6.2    Patent Landscape
    6.3    Clinical Trials Synopsis (Additional Insight)
7    Industry Dynamics
    7.1    Industry Drivers and Constraints
    7.2    Porter Five Forces
    7.3    SWOT Analysis
    7.4    Key Demand Indicators 
    7.5    Key Price Indicators 
    7.6    Industry Events, Initiatives, and Trends
    7.7    Value Chain Analysis
8    Supplier Landscape
    8.1    Company Profiles
        8.1.1    Biosense Webster
            8.1.1.1    Company Overview
            8.1.1.2    Product Portfolio
            8.1.1.3    Demographic Reach and Achievements
            8.1.1.4    Mergers and Acquisitions
            8.1.1.5    Certifications
        8.1.2    Abbott Laboratories
            8.1.2.1    Company Overview
            8.1.2.2    Product Portfolio
            8.1.2.3    Demographic Reach and Achievements
            8.1.2.4    Mergers and Acquisitions
            8.1.2.5    Certifications
        8.1.3    Medtronics PLC
            8.1.3.1    Company Overview
            8.1.3.2    Product Portfolio
            8.1.3.3    Demographic Reach and Achievements
            8.1.3.4    Mergers and Acquisitions
            8.1.3.5    Certifications
        8.1.4    Boston Scientific Corporation
            8.1.4.1    Company Overview
            8.1.4.2    Product Portfolio
            8.1.4.3    Demographic Reach and Achievements
            8.1.4.4    Mergers and Acquisitions
            8.1.4.5    Certifications
        8.1.5    Acutus Medical
            8.1.5.1    Company Overview
            8.1.5.2    Product Portfolio
            8.1.5.3    Demographic Reach and Achievements
            8.1.5.4    Mergers and Acquisitions
            8.1.5.5    Certifications
        8.1.6    Microport Scientific Corporation
            8.1.6.1    Company Overview
            8.1.6.2    Product Portfolio
            8.1.6.3    Demographic Reach and Achievements
            8.1.6.4    Mergers and Acquisitions
            8.1.6.5    Certifications
        8.1.7    CoreMap Inc.
            8.1.7.1    Company Overview
            8.1.7.2    Product Portfolio
            8.1.7.3    Demographic Reach and Achievements
            8.1.7.4    Mergers and Acquisitions
            8.1.7.5    Certifications
        8.1.8    APN Health LLC
            8.1.8.1    Company Overview
            8.1.8.2    Product Portfolio
            8.1.8.3    Demographic Reach and Achievements
            8.1.8.4    Mergers and Acquisitions
            8.1.8.5    Certifications
        8.1.9    BioSig Technologies Inc.
            8.1.9.1    Company Overview
            8.1.9.2    Product Portfolio
            8.1.9.3    Demographic Reach and Achievements
            8.1.9.4    Mergers and Acquisitions
            8.1.9.5    Certifications
        8.1.10    Biotronik SE and Co KG
            8.1.10.1     Company Overview
            8.1.10.2    Product Portfolio
            8.1.10.3    Demographic Reach and Achievements
            8.1.10.4    Mergers and Acquisitions
            8.1.10.5    Certifications
        8.1.11    Koninklijke Philips NV
            8.1.11.1    Company Overview
            8.1.11.2    Product Portfolio
            8.1.11.3    Demographic Reach and Achievements
            8.1.11.4    Mergers and Acquisitions
            8.1.11.5    Certifications
        8.1.12     Angiodynamics
            8.1.12.1    Company Overview
            8.1.12.2    Product Portfolio
            8.1.12.3    Demographic Reach and Achievements
            8.1.12.4    Mergers and Acquisitions
            8.1.12.5    Certifications
9    Recommendations and Discussion 
10    Pricing Models and Strategies (Additional Insight)

    10.1    Overview
    10.2    Cost Model
        10.2.1    Manufacturing Cost Analysis
        10.2.2    Procurement Cost Analysis
        10.2.3    Clinical Trial Cost Factors
    10.3    Pricing Strategies
        10.3.1    Competitor pricing Analysis
        10.3.2    Key assessment of product attributes
        10.3.3    Pricing Benchmark
11    Global Cardiac Mapping System Distribution Model (Additional Insight)
    11.1    Overview
    11.2    Potential Distributors
    11.3    Key Parameters for Distribution Partner Assessment

Key Questions Answered in the Report

Cardiac mapping systems are the mapping devices used to measure the heart’s electrical impulses and create an extensive three-dimensional image of the heart’s anatomy.

The market is expected to grow at a CAGR rate of 8.50% during the forecast period.

The two major types of cardiac mapping systems are contact mapping-based and non-contact mapping-based systems.

The cardiac mapping systems are used to diagnose and manage atrial fibrillation, atrial flutter, atrioventricular nodal reentry tachycardia (AVNRT) and other arrhythmias.

The major factors driving the growth of the cardiac mapping systems market are the rising prevalence of cardiovascular disorders and novel product launches and approvals.

The different end users in this market are hospitals, testing laboratories, research  laboratories, and individuals.

The regions involved in this market are North America, Latin America, Asia Pacific, Europe and LATAM.

North America accounts for the maximum cardiac mapping systems market share.

The incorporation of magnetic technology, hybrid of impedance and magnetic-based technologies, artificial intelligence, etc., are some emerging technologies in cardiac mapping systems.

The key companies are Biosense Webster, Abbott Laboratories, Medtronics PLC, Boston Scientific Corporation, Acutus Medical, Microport Scientific Corporation, CoreMap Inc., APN Health LLC, BioSig Technologies Inc., Biotronik SE and Co KG, Koninklijke Philips NV, Angiodynamics, among others.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER